My Block Skin develops inclusive sun care technologies that deliver invisible, high-performance UV protection for every skin tone.
Market Opportunity:
Traditional sunscreens often leave a visible white cast, discouraging daily use among millions of consumers, particularly those with deeper skin tones. My Block Skin is developing next-generation sun care technologies that combine superior cosmetic elegance with clinically validated UV protection, addressing a rapidly growing global skin health and sun care market.
Technology:
My Block Skin combines advanced formulation chemistry with AI-assisted research to develop next-generation inclusive sunscreen technologies. The company currently commercializes a transparent SPF 50 sunscreen while developing a patent-pending transparent mineral sunscreen platform designed to eliminate white cast without compromising broad-spectrum UV protection.
Advantages:
- Invisible on all skin tones
- Patent-pending technology
- AI-assisted formulation
- Broad-spectrum UV protection
- Commercially validated platform
Development Stage:
- Commercial Sunscreen Platform: Marketing; Transparent Mineral Sunscreen Platform: Pre-clinical
IP Protection:
- U.S. Provisional Patent Application No. 63/953,022
Title: Eutectic Solvents and Nanoparticle Compositions and Associated Methods
Filing Date: January 2, 2026
Inventor: Jason Williams
Applicant: My Block Skin Inc.
PLW Reference: 11088-11175-PR
Select Press Releases/Publications/Presentations:
- 2026 L’Oreal USA Inclusive Beauty Fund Recipient
- British GQ Feature
- Soho House Feature
- Mintel UK Skincare Report Feature
Contact:
Website: myblockskin.com
Phone: (877) 288-4227
Email: hello@myblockskin.com
LinkedIn: linkedin.com/company/myblockskin
Instagram: instagram.com/myblockskin
TikTok: tiktok.com/@myblockskin
- Anaco
- CDR3 Therapeutics, Inc.
- Dalton Bioanalytics
- Diatom Biolab
- Eximius Diagnostics
- Giant BioSystems
- Hikari Medical Technologies
- ImmunoVec
- MedStat AI Inc.
- Mervyn's Petcare, Inc.
- Meteor Biotech, LLC
- My Block Skin, Inc.
- Nanomega CryoAI
- NEXT-TFX, Inc.
- Paralos Bioscience Inc.
- Pelage Pharmaceuticals
- Pluto Immunotherapeutics
- Protean Research, Inc.
- Purpose Bio
- RaizDx
- RiboForge
- Saku Biosciences, Inc.
- SolGrapH, Inc.
- Sorriso Pharmaceuticals
- Thermeutics, Inc.
- Veergen, Inc.
- Yuyu Bio, Inc.